title: Exogenous expression of Fas-ligand or CrmA prolongs the survival in rat liver transplantation.
abstract: Modulation of donor organs by transfection of a gene encoding immmunosuppresive molecules has been recognized as a less toxic approach to prevent allograft rejection. Fas-ligand (FasL) plays a critical role in activation-induced cell death of activated cytotoxic lymphocytes. This may provide a potential for induction of "immune privileged sites" to escape the host immune surveillance system. Cytokine response modifier A (CrmA), a gene product of cowpox virus, blocks caspase as well as perforin/granzyme-mediated apoptotic pathways. Therefore, it may suppress intragraft apoptosis. The aim of the present study was to investigate whether transfection of FasL or CrmA genes prolonged the survival of rat liver allografts. Using the high responder rat combination of DA (RT-1(a)) donor to LEW (RT-1(1)) recipient, we performed orthotopic liver transplantation with subsequent delivery of adenoviral vectors containing FasL, CrmA, or LacZ, at a dose of 1 x 10(9) pfu via a recipient tail vein using a Cre-mediated gene expression system. Recipient survival was assessed as well as immunohistochemical examination of the grafts for anti-CD2, TUNEL, and H&E staining. Statistical analysis was performed with the Mann-Whitney U test. The therapeutic groups showed significantly prolonged recipient survival compared with the LacZ-treated control group. Histologic analysis revealed reduced hepatocyte apoptosis in the CrmA-treated group and increased apoptosis of infiltrating mononuclear cells in the FasL-treated group. These data suggested that FasL and CrmA may be potent genes to prolong rat liver allograft survival.
authors.affiliation: Laboratory of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Adachi
authors.forename: M
authors.initials: M
authors.lastname: Fujino
authors.forename: Y
authors.initials: Y
authors.lastname: Kitazawa
authors.forename: N
authors.initials: N
authors.lastname: Funeshima-Fuji
authors.forename: S
authors.initials: S
authors.lastname: Takahara
authors.forename: H
authors.initials: H
authors.lastname: Kimura
authors.forename: X-K
authors.initials: XK
authors.lastname: Li
mesh_terms: D000818:Animals; D053222:Fas Ligand Protein / Q000235:genetics*; D005822:Genetic Vectors; D006084:Graft Rejection; D006085:Graft Survival / Q000502:physiology*; D016031:Liver Transplantation / Q000502:physiology*; D023421:Models, Animal; D051381:Rats; D011917:Rats, Inbred Lew; D015843:Serpins / Q000235:genetics; D014162:Transfection; D014184:Transplantation, Homologous; D014764:Viral Proteins / Q000235:genetics; D001616:beta-Galactosidase / Q000235:genetics
chemical_list: D053222:Fas Ligand Protein; C505662:Faslg protein, rat; D015843:Serpins; D014764:Viral Proteins; C074641:interleukin-1beta-converting enzyme inhibitor; D001616:beta-Galactosidase